Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,48 USD | -0,31% | -6,43% | -26,86% |
20/05 | PRIME MEDICINE, INC. : HC Wainwright past advies aan | ZM |
16/05 | PRIME MEDICINE, INC. : Citigroup verhoogt advies van Neutraal naar Kopen | ZM |
Vakgebied
Aantal werknemers: 234
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 70 | 01-07-20 | |
Allan Reine
DFI | Director of Finance/CFO | 49 | 17/01 |
Chief Operating Officer | 52 | 01-09-22 | |
Jeremy Duffield
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-21 |
Ann Lee
CTO | Chief Tech/Sci/R&D Officer | 62 | 01-10-21 |
Mohammed Asmal
CTO | Chief Tech/Sci/R&D Officer | - | - |
Fubao Wang
LAW | General Counsel | - | - |
Karen Brown
LAW | General Counsel | - | - |
Niamh Alix
HRO | Human Resources Officer | - | 01-06-22 |
Carman Alenson
AUD | Comptroller/Controller/Auditor | 58 | 01-08-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 01-12-21 | |
Robert Nelsen
BRD | Director/Board Member | 60 | 01-09-20 |
Michael Kelly
BRD | Director/Board Member | 67 | 01-11-21 |
David Schenkein
BRD | Director/Board Member | 66 | 13-09-19 |
Chief Executive Officer | 70 | 01-07-20 | |
Director/Board Member | 46 | 10-05-23 | |
Thomas Cahill
BRD | Director/Board Member | 37 | 01-11-21 |
Wendy Chung
BRD | Director/Board Member | 55 | 01-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 120 030 813 | 88 249 113 ( 73,52 %) | 0 | 73,52 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,86% | 749 mln. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |
- Beurs
- Aandelen
- Koers PRME
- Onderneming Prime Medicine, Inc.